insulin

As nouns the difference between insulin and hyperinsulinaemia

is that insulin is insulin (polypeptide hormone) while hyperinsulinaemia is (pathology) the presence of an unusually high level of insulin in the bloodstream.

As a noun insulin

is insulin (polypeptide hormone).

As an adjective noninsulin is

not of or pertaining to insulin.

As nouns the difference between insulin and nateglinide

is that insulin is insulin (polypeptide hormone) while nateglinide is a meglitinide drug for the treatment of type ii diabetes that lowers blood glucose by stimulating the release of insulin from the pancreas.

As nouns the difference between insulin and streptozotocin

is that insulin is insulin (polypeptide hormone) while streptozotocin is a naturally-occurring chemical that is particularly toxic to the insulin-producing beta cells of the pancreas in mammals, used to treat certain cancers.

As nouns the difference between insulin and phogrin

is that insulin is insulin (polypeptide hormone) while phogrin is (protein) a protein present on insulin-secretory granules of pancreatic beta cells.

As nouns the difference between insulin and diazoxide

is that insulin is insulin (polypeptide hormone) while diazoxide is a potassium channel activator which causes local relaxation in smooth muscle by increasing membrane permeability to potassium ions, used as a vasodilator to treat hypertension and in diabetes to decrease the secretion of insulin.

As a noun insulin

is insulin (polypeptide hormone).

As an adjective insulinlike is

resembling insulin or some aspect of it.

As nouns the difference between insulin and octreotide

is that insulin is insulin (polypeptide hormone) while octreotide is (pharmacy) an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon and insulin than the natural hormone.

As nouns the difference between insulin and insulinoma

is that insulin is a polypeptide hormone that regulates carbohydrate metabolism while insulinoma is a tumour of the pancreas that secretes insulin.

As nouns the difference between insulin and sulfonylurea

is that insulin is a polypeptide hormone that regulates carbohydrate metabolism while sulfonylurea is any of a class of antidiabetic drugs that act by increasing insulin release from the beta cells in the pancreas.